Rational modulation of the innate immune system for neuroprotection in ischemic stroke
about
The Effects of Hypoxia and Inflammation on Synaptic Signaling in the CNSInnate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist PerspectiveBalancing the immune response in the brain: IL-10 and its regulationHeterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and RepairUpdate on Inflammatory Biomarkers and Treatments in Ischemic StrokeTargeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery.Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injuryPotential role of microRNA-7 in the anti-neuroinflammation effects of nicorandil in astrocytes induced by oxygen-glucose deprivationInterferon-β Modulates Inflammatory Response in Cerebral IschemiaFractalkine Receptor Deficiency Is Associated with Early Protection but Late Worsening of Outcome following Brain Trauma in MiceNeuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK PathwayMetabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients.Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation.The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.Association Between Serum Tumor Necrosis Factor Receptor 1 and Trajectories of Functional Status: The Northern Manhattan Study.Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response.Polarizing the immune system towards neuroprotection in brain ischemia.Impact of Comorbidities on Acute Injury and Recovery in Preclinical Stroke Research: Focus on Hypertension and Diabetes.Friend or Foe? Resident Microglia vs Bone Marrow-Derived Microglia and Their Roles in the Retinal Degeneration.Neuroimmune Response in Ischemic Preconditioning.Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes.The effect of captopril on the expression of MMP-9 and the prognosis of neurological function in herpes simplex encephalitis mice.Novel Therapeutic Effects of Leonurine On Ischemic Stroke: New Mechanisms of BBB IntegrityAnti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke.Effects of the Rabdosia rubescens total flavonoids on focal cerebral ischemia reperfusion model in rats.(+)-Borneol is neuroprotective against permanent cerebral ischemia in rats by suppressing production of proinflammatory cytokines.Monocyte-lymphocyte cross-communication via soluble CD163 directly links innate immune system activation and adaptive immune system suppression following ischemic stroke.Osteopontin Augments M2 Microglia Response and Separates M1- and M2-Polarized Microglial Activation in Permanent Focal Cerebral Ischemia.Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells.Correction to: Neuroimmune Response in Ischemic Preconditioning.Endothelial nitric oxide synthase inhibition triggers inflammatory responses in the brain of male rats exposed to ischemia-reperfusion injury.Anti-inflammatory effects of ADAMTS-4 in a mouse model of ischemic stroke.Polymerase delta-interacting protein 2 deficiency protects against blood-brain barrier permeability in the ischemic brain.Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke.A Combination of Three Repurposed Drugs Administered at Reperfusion as a Promising Therapy for Postischemic Brain Injury.Paradigm Shift to Neuroimmunomodulation for Translational Neuroprotection in Stroke.On the Role of Store-Operated Calcium Entry in Acute and Chronic Neurodegenerative Diseases.Cell Type-Specific Mechanisms in the Pathogenesis of Ischemic Stroke: The Role of Apoptosis Signal-Regulating Kinase 1.
P2860
Q26768430-673558B4-C97B-4C99-9B41-85E67E585DDBQ26774441-905C75EF-B646-4420-B1FF-25DAA6D79771Q28073951-723D31B4-2A64-43DC-BEE8-B6DDF6F6DCEFQ28078211-F903C08C-9B93-4C55-8A10-1E2F92B1C2FCQ28078744-242A0768-2BA3-4597-9C9A-FF987AF16A91Q33695357-8797B301-9492-47AB-BF38-4D4F26BEDAA2Q36534816-FB020415-ABCE-43EC-9150-6A508A8AAFCFQ36671471-D5C2B8C1-720F-4236-8A1A-5F1057678C07Q36877674-70B812BF-E454-4E43-8ED7-A1F9A3160E59Q36966520-7DF056C6-2F3F-423E-8EEE-1AD711AB2B4FQ37125129-679C881A-AAA8-47B6-B70D-172D64D5BE11Q37286315-9B08F8D6-D2BB-4692-B249-3D841C51CFEEQ37510154-6F3EE5FE-D7E5-499E-B9FB-DDE6EA0ADC49Q37577170-48784A8F-1994-464C-BE0B-F1313D5580CDQ38253558-55670510-624C-471B-AF0B-CD0521796244Q38403465-CB40EC3D-40F9-48CA-B737-B227863C27F9Q38602859-CD55171C-E7C3-466B-A2AF-6F1A2A5A37FEQ38717022-552E8309-CB73-4E02-88A2-CFE4A97E6C2CQ38793026-CA84E77F-EE48-46A5-8197-EB346B9D0910Q38851309-C8F2FC07-CCEA-4BBC-89BF-A581855DA207Q38927962-C2DFBE34-D473-4F7E-AAC4-06502063F8F8Q39116577-F964ABCB-0544-4783-A3A5-61655343B9FCQ40530815-AD417D97-5AD4-47EA-9086-346C30C56559Q40632807-3077A12B-A037-4762-AADF-1E7E6CFAA859Q41037865-209D2125-BB09-4620-A506-F89CADFD29B6Q41314097-B5B8B8E4-41AA-4AFD-9D47-FE8F95A3E2DEQ41958106-5B4DA25A-E863-4172-9A32-FDA1B65EF399Q42343600-E8AEF28A-1527-4977-8008-8539F2406F3AQ42374943-A79F44B5-8B27-4361-BB21-5D20C45508ABQ44544064-6BB9729D-B393-4C59-B3F8-3D399DDF2922Q46488331-0FF30846-02B8-4F3C-A9D0-991BE0D015E8Q47982879-82F9247D-C203-45DD-96C9-189E050EBDDDQ48284118-B4F373E2-D133-4B7F-BC48-F8D2F851521EQ48677986-178329DB-3E57-4ED4-91DE-EE58A2127EC4Q49921008-2A5140A3-BBCC-41FF-B102-554A1C73EA7DQ51741486-302837BA-C293-4F6D-B9D4-77E306E7D2E7Q52091138-940F5236-E51E-45DC-8A40-78E747B44FA2Q52564678-4263CF31-3F7B-4473-8C00-A408266E3D2FQ52721231-EA97D85F-88AB-4965-8349-F085FFCF5F13Q54111091-CEF09D8A-3BB1-4FA2-81ED-09B10BB9CE7A
P2860
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@ast
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@en
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@nl
type
label
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@ast
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@en
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@nl
prefLabel
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@ast
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@en
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@nl
P2860
P50
P3181
P356
P1476
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
@en
P2093
Cristina Tassorelli
P2860
P3181
P356
10.3389/FNINS.2015.00147
P407
P50
P577
2015-04-29T00:00:00Z